Ein Arzt berät einen Patienten (Symbolbild).
Donnerstag, 23.02.2017 14:45 von | Aufrufe: 36

Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2016

Ein Arzt berät einen Patienten (Symbolbild). © TommL / Vetta / Getty Images https://www.gettyimages.de/

PR Newswire

OWINGS MILLS, Md., Feb. 23, 2017 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, will announce financial results for the fourth quarter and fiscal year ended December 31, 2016 on Thursday, March 9, 2017, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Daniel R. Chard, Chief Executive Officer, and Timothy Robinson, Chief Financial Officer.

The conference call is scheduled to begin at 4:30 p.m. ET on March 9, 2017. The call will be broadcast live over the Internet hosted at the Investor Relations section of Medifast's website at www.MedifastNow.com, and will be archived online through March 23, 2017. In addition, listeners may dial (855) 560-2579.

A telephonic playback will be available from 6:30 p.m. ET, March 9, 2017, through March 16, 2017. Participants can dial (877) 344-7529 to hear the playback and enter passcode 10102163.

About Medifast®:

Medifast (NYSE: MED) is the leading easy-to-use provider of clinically proven weight-loss and healthy living products and programs. Medifast aims to help customers lead a healthier lifestyle through a holistic approach to weight-loss and weight management. Medifast's proven results are based on the use of structured meal plans featuring Medifast Meals, which are nutritionally designed to assist customers with successful weight-loss and weight management. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto www.MedifastNow.com.

About Take Shape For Life®:


ARIVA.DE Börsen-Geflüster

Kurse

33,32 $
+3,06%
Medifast Inc. Chart

Take Shape For Life® is a thriving, vibrant community that is redefining the path to wellbeing and Optimal Health™.  It achieves this through a network of Independent Health Coaches, who provide support and personal encouragement to help Clients safely and effectively reach and sustain a healthy weight, and adopt habits for a lifetime of health. Within the Trilogy of Optimal Health, Take Shape For Life® offers individuals an opportunity to create sustainable health in all areas of their lives – building a healthy body, developing a healthy mind, and generating healthy finances.  Take Shape For Life® provides Health Coaches with tools and support; an innovative, leading-edge lifestyle program; training and knowledge; and best of all, a community of like-minded individuals working toward the common goal of getting America healthy.  In 2016, Take Shape For Life® was ranked in the top 20 of the Direct Selling Association's largest companies, and is a Code of Ethics member of the same organization.

MED-F

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medifast-inc-to-announce-financial-results-for-the-fourth-quarter-and-fiscal-year-ended-december-31-2016-300412530.html

SOURCE Medifast, Inc.

Werbung

Mehr Nachrichten zur Medifast Inc. Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.